Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

February 22, 2016

As the rainy season approaches in Wajir, northeastern Kenya, Doctors Without Borders/Médecins Sans Frontières (MSF) warns that the substandard water and sanitation situation is creating ideal conditions for a future increase in cholera cases. While today patient numbers in the cholera treatment center in Wajir Hospital are stable, MSF urges for an immediate improvement in sanitation services to avoid another spike in cases.

February 18, 2016

JUBA, SOUTH SUDAN — At least 18 people were killed in armed conflict that erupted last night in the Protection of Civilians site in Malakal, South Sudan, including two South Sudanese staff members of Doctors Without Borders/Médecins Sans Frontières (MSF) who were attacked in their homes, the organization said today.

Teams worked through the night to treat 36 wounded people at the MSF hospital in Malakal, including an MSF staff member. At least 25 patients had suffered gunshot wounds and eight required surgery. More casualties are continuing to arrive today.

February 18, 2016

Statement delivered by Dr. Joanne Liu, International President of Doctors Without Borders/Médecins Sans Frontières (MSF), at the Palais des Nations, Geneva, February 18, 2016.

Today in Syria, the abnormal is now normal. The unacceptable is accepted.

Relentless, brutal, and targeted attacks on civilians are the dominant feature of this war. In addition to the countless numbers of dead, hundreds of thousands of people are fleeing for their lives. Many of them are trapped, denied the fundamental right to flee.

February 18, 2016

MSF reports more than one in three wounded and dead are women and children.

February 15, 2016

Gaziantep/Paris—At least seven people were killed and eight are missing and presumed dead following a Monday morning attack in northern Syria that destroyed a hospital supported by Doctors Without Borders/Médecins Sans Frontières (MSF) the international medical humanitarian organization said today. (As of February 17, 2016, these numbers now stand at nine hospital staff members and 16 patients/caretakers killed in the attack).

February 11, 2016

Doctors Without Borders/Médecins Sans Frontières (MSF) issued the following statement today from Aurelie Ponthieu, MSF humanitarian affairs advisor on displacement, after NATO announced its response to migration in the Aegean Sea:

February 10, 2016

Delhi/New York—A patient living with HIV in India has filed an application to try to block ViiV Healthcare from being granted patents on two new critical HIV drugs, the medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) announced today.

February 10, 2016

Medical services disrupted in many areas and basic aid lacking for 30,000 newly displaced people.

Pages